Search Results for: emergency use authorization

By Kuldip K. Ambastha Quidel Corporation (QDEL) is an American company in the diagnostic healthcare product space. Its offerings are sold worldwide. On Friday, May 8, 2020, the company received emergency use authorization for a COVID-19 antigen test from the U.S. Food and Drug Administration. (Emergency use authorization is a new public health testing category …

Continue reading “What Caught Our Attention in the Investment World? – Week of November 9-13, 2020”

By Kuldip K. Ambastha Novavax, Inc. (NVAX), a clinical-stage vaccine company, had its stock price fall by -17.2% per share on Thursday, June 9, 2022. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of December 27-31, 2021; By Kuldip K. Ambastha.”) In 1Q2022, earnings per share plus total …

Continue reading “What Caught Our Attention in the Investment World? – Week of June 6-10, 2022”

By Kuldip K. Ambastha Novavax, Inc. (NVAX), a clinical-stage vaccine company, had four negative daily returns and one positive daily return for its shares during this past trading week per the table displayed here. Worldwide, the coronavirus pandemic continues to be a serious public health issue, especially through the Delta and Omicron COVID-19 variants. Novavax …

Continue reading “What Caught Our Attention in the Investment World? – Week of December 27-31, 2021”